Question

I am a breastfeeding mother and i want to know if it is safe to use Glucurono-2-amino-2-deoxyglucoglucan sulfate? Is Glucurono-2-amino-2-deoxyglucoglucan sulfate safe for nursing mother and child? Does Glucurono-2-amino-2-deoxyglucoglucan sulfate extracts into breast milk? Does Glucurono-2-amino-2-deoxyglucoglucan sulfate has any long term or short term side effects on infants? Can Glucurono-2-amino-2-deoxyglucoglucan sulfate influence milk supply or can Glucurono-2-amino-2-deoxyglucoglucan sulfate decrease milk supply in lactating mothers?

Glucurono-2-amino-2-deoxyglucoglucan sulfate lactation summary

Glucurono-2-amino-2-deoxyglucoglucan sulfate usage has low risk in breastfeeding
  • DrLact safety Score for Glucurono-2-amino-2-deoxyglucoglucan sulfate is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of Glucurono-2-amino-2-deoxyglucoglucan sulfate may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that Glucurono-2-amino-2-deoxyglucoglucan sulfate may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of Glucurono-2-amino-2-deoxyglucoglucan sulfate low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using Glucurono-2-amino-2-deoxyglucoglucan sulfate We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Glucurono-2-amino-2-deoxyglucoglucan sulfate usage in lactation

Heparin-like glycosaminoglycan which is a mixture of low molecular weight heparin (80%) and dermatan sulfate (20%) that has hypolipaemic and antithrombotic properties and used for treatment of venous insufficiency.It does not have significant effects on coagulation but some protective properties on vascular endothelium is attributed. At latest update on excretion into breast milk no published data were found. Pharmacokinetic data (large volume of distribution and high molecular weight) make it unlikely the passage into milk in significant amounts. Until more published data about this drug regarding breastfeeding is available, a safer alternative should be used, especially during the neonatal period and in case of prematurity.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.